CTLA4 and neoplasm: As shown in Figure 6C and summarized in Supplementary Table 3, results revealed that treatment with plant-produced anti-CTLA-4 significantly repressed tumor weight (TGITW = 96.93%) similarly to that of Yervoy®-treated group (TGITW = 99.20%).